New combo therapy shows promise for rare blood cancer
NCT ID NCT04624906
First seen Feb 04, 2026 · Last updated Apr 30, 2026 · Updated 8 times
Summary
This study tests a new drug, acalabrutinib, added to standard chemotherapy for people with untreated Waldenstrom's macroglobulinemia, a rare blood cancer. About 63 participants will receive the combination for up to a year. The goal is to see if this approach improves response rates and controls the disease better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WALDENSTROM MACROGLOBULINEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de Quebec - University Laval
Laval, Quebec, Canada
-
Cross Cancer Institute
Edmonton, Alberta, Canada
-
Hamilton Health Sciences Centre - Juravinksi
Hamilton, Ontario, Canada
-
McGill University Health Centre
Montreal, Quebec, Canada
-
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
-
The Ottawa Hospital
Ottawa, Ontario, Canada
-
Tom Baker Cancer Centre
Calgary, Alberta, Canada
-
Vancouver General Hospital
Vancouver, British Columbia, Canada
Conditions
Explore the condition pages connected to this study.